Organon suspends earnings call as Sun Pharma merger proceeds, reports Q3 results
Organon filed its third-quarter 2026 10-Q and furnished supplemental non-GAAP data instead of holding its usual earnings release and call, citing the pending Sun Pharma merger.
SEC filing